I’ve Worked With Nearly 100 Franchise Owners. Here’s What the Most Successful Ones Almost Always Have in Common.

FactSet: Countering Disruption Fears By Using AI To Boost Margins

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

The Top HealthTech Questions Landing On Our Desks

Treasury 10-Year Yield Hits Highest Since 2002 on Rate Outlook

Active Energy Group secures £1.3M UAE funding facility